Photo by Louis Reed

The Changing Landscape of Multiple Sclerosis Treatment

Oct 16, 2019

In the first quarter of 2019, two new Multiple Sclerosis (MS) medications were approved by the Food and Drug Administration (FDA) and there are many more on the horizon for approval. MS is a complicated disease that impacts approximately 1 million people in the U.S. and affects every patient differently. It attacks the central nervous system, damaging nerve fibers, causing varied symptom exacerbations and leading to progressive disability. While there is no cure for this condition, there have been substantial treatment advances in the last 20 years…

Read the full story at